TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced the launch of its TRxADE Discount Card. The new offering empowers independent pharmacies to continue providing their customers with deeply discounted drug pricing while concurrently protecting margins and remaining at the forefront of patient care. “We are pleased to announce our TRxADE Discount Card program, the T-Rx(TM) Savings Card, offering our network of independents access to competitive prescription savings for their customers while concurrently maintaining a reasonable transaction-level margin profile — a feature unique to our TrxadeHSO(TM) solution, unlike other well established discount card providers,” said Prashant Patel, RPh, president of TRxADE Health. “Other major prescription drug discount providers either exclude independents from the network or offer preferred rates to retail enterprise partners, resulting in higher fees for the independents and their patients when their benefit is utilized by the patient. Our model uniquely provides a win-win situation for all key stakeholders while further enhancing the value of the TRxADE platform to the independent pharmacy community.”
To view the full press release, visit https://ibn.fm/WCEWN
About TRxADE Health Inc.
TRxADE Health is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The company operates the TRxADE drug procurement marketplace serving a total of 12,950+ members nationwide, fostering price transparency and, under the Bonum Health brand, offering patient centric telehealth services. For info on TRxADE Health, please visit the company’s IR website at investors.trxadegroup.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
